Skip to main content

Revolutionizing Solid Tumor Treatment: Prof. Magdalena Król’s Inspiring BIO-Europe Speech

Prof. Magdalena Król, CEO of Cellis, wowed the audience at BIO-Europe in Munich, Germany with her captivating speech on “Breakthrough Macrophage-Based Immunotherapy for Solid Tumors.”

A big shoutout to the organizers for creating a platform for groundbreaking ideas. We’re inspired and eager to see how this innovation will shape the future of cancer treatment! 🌟🙌 #BIOEurope #Immunotherapy #CellisInnovates